z-logo
open-access-imgOpen Access
Novel Interventional Approaches for ALI/ARDS: Cell-Based Gene Therapy
Author(s) -
Yinggang Zhu,
Jieming Qu,
Jing Zhang,
Hongni Jiang,
JinFu Xu
Publication year - 2011
Publication title -
mediators of inflammation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.37
H-Index - 97
eISSN - 1466-1861
pISSN - 0962-9351
DOI - 10.1155/2011/560194
Subject(s) - ards , medicine , acute respiratory distress , intensive care medicine , genetic enhancement , stem cell therapy , critically ill , bioinformatics , cell therapy , stem cell , lung , gene , biology , biochemistry , transplantation , genetics
Acute lung injury (ALI) and its more severe form, acute respiratory distress syndrome (ARDS), continue to be a major cause of morbidity and mortality in critically ill patients. The present therapeutic strategies for ALI/ARDS including supportive care, pharmacological treatments, and ventilator support are still controversial. More scientists are focusing on therapies involving stem cells, which have self-renewing capabilities and differentiate into multiple cell lineages, and, genomics therapy which has the potential to upregulate expression of anti-inflammatory mediators. Recently, the combination of cell and gene therapy which has been demonstrated to provide additive benefit has opened up a new chapter in therapeutic strategy and provides a basis for the development of an innovative approach for the prevention and treatment of ALI/ARDS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom